Apyx Medical Corporation (APYX) vs Polaryx Therapeutics, Inc. Common Stock (PLYX)
A side-by-side comparison of Apyx Medical Corporation and Polaryx Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APYX
Apyx Medical Corporation
$2.61HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
PLYX
Polaryx Therapeutics, Inc. Common Stock
$2.12HealthcareDelayed quote: Oct 6, 2026, 1:43 PM EDT
Total return — APYX vs PLYX
growth of $100 · dividends reinvested · last 1yAPYX -40.9% (-40.9%/yr)PLYX -94.1% (-94.1%/yr)APYX compounded faster over this window
Log scale — wide-divergence pair
APYX PLYX
APYX vs PLYX: by the numbers
- •APYX is the larger company ($110M vs $106M market cap).
- •Both run net losses; PLYX's is the smaller (0.00% vs -14.78% net margin).
Metrics side by side
Valuation
| Metric | APYX | PLYX |
|---|---|---|
| P/S ratio | 1.88 | N/A |
| P/B ratio | 10.29 | 9.66 |
Profitability
| Metric | APYX | PLYX |
|---|---|---|
| Gross margin | 33.94% | 0.00% |
| Operating margin | -6.06% | 0.00% |
| Net margin | -14.78% | 0.00% |
| ROE | -80.97% | -62.61% |
| ROIC | -6.84% | -47.75% |
Growth (annualized)
| Metric | APYX | PLYX |
|---|---|---|
| Revenue CAGR (5Y) | 8.82% | N/A |
| Total return CAGR (5Y) | -28.10% | N/A |
Go deeper
Dig into the metrics
Apyx Medical ROEPolaryx Therapeutics, Inc. Common Stock ROEApyx Medical operating marginPolaryx Therapeutics, Inc. Common Stock operating marginApyx Medical revenue growthPolaryx Therapeutics, Inc. Common Stock revenue growthApyx Medical free cash flowPolaryx Therapeutics, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.